The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.25
Bid: 6.00
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.50 (8.333%)
Open: 6.25
High: 6.25
Low: 6.25
Prev. Close: 6.25
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kromek launches the D5 RIID radiation detector

3 Dec 2020 07:00

RNS Number : 3535H
Kromek Group PLC
03 December 2020
 

This is an RNS Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Group's performance. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

3 December 2020

 

Kromek Group plc

("Kromek" or the "Group")

 

Kromek launches the D5 RIID high performance radiation detector

World's smallest RIID with high accuracy and ultra-low false alarm rate

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces the launch of the D5 RIID, the world's smallest high performance radioisotope identification device ("RIID"). The ruggedised device, with ultra-low false alarm rate, is designed for military, homeland security and industrial use.

 

The D5 RIID was developed under a programme with the Defense Threat Reduction Agency of the US Department of Defense. It detects a wide range of sources, including special nuclear material and mixed, shielded and heavily masked configurations. It provides high accuracy dose measurement and has an industry-leading ultra-low false alarm rate of less than 1 in 24 hours. The D5 RIID combines this advanced performance with being small, lightweight and easy-to-use - capable of being operated in one hand. It can also be used when wearing all levels of PPE, including gloves. It offers multiple modes of configuration, including being able to provide app-based training, and can be easily integrated into standard and custom networks.

 

It is the first device to be launched in Kromek's new D5 product range, which expands the Group's radiation detection portfolio to encompass devices specifically designed for more challenging use cases and harsh environments. This next-generation of product has a larger crystal, which enables higher accuracy and sensitivity - capable of detecting mixed, shielded and heavily masked configurations including special nuclear material - as well as being ruggedised.

 

Dr Arnab Basu, CEO of Kromek, said: "We are delighted to have launched the D5 RIID, which truly sets a new benchmark in radioisotope identification. The level of accuracy, combined with small size, far exceeds competing military standard detectors, enabling the rapid identification of radiological threats. As the first of our new D5 range, this device expands our portfolio to provide products ideal for use in harsh environments and for more challenging applications alongside our existing D3 solutions that are aimed at fleet deployment for large-scale networking across urban areas. We are proud to be continuing to drive innovation in this crucial area to enable rapid, informed decisions to be made in response to a radiation threat wherever it may appear."

 

For further information on the D5 RIID, please visit: https://www.kromek.com/product/d5-riid/

 

D5 RIID Detector Specification

Detector type

CLLBC - Gamma and Neutron detection

Detector size

1.5" diameter x 1.5" long

Gamma energy range

30 keV to 3 MeV

Gamma dose rate range

0.01 µSv/h (10 µR/h) to 100 µSv/h (10 mR/h) spectroscopic

100 µSv/h (10 mR/h) to 1 Sv/h (100 R/h) high dose sensor

Dose accuracy

± 10% for Cs137

Gamma resolution

Typically 3.5% @ 662 keV

Area efficiency*

1.62 relative to a 2" x 2" Ø Nal

Neutron sensitivity

𝐴𝜖𝑡= 16cm2

Neutron detector gamma rejection

Better than 10-7 meets ANSI N42.34 (2015) section 6.7

Operational temperature range

-20°C to 50°C

Humidity

Up to 93% RH

Moisture/dust

IP67

Batteries

Primary cells: 2 x AA field replaceable

Internal rechargeable: Li-Ion >2.25 Ah

Battery capacity (primary cells)

24 hours at normal background

Battery charging

1 hour to 50% capacity, 4 hours to full charge

Wired interface

USB-C

Wireless interface

Bluetooth

Wi-Fi 802.11a/b/c/g/n

Firmware updating

Update over USB

Display

2.8" colour antiglare with backlight suitable for both high and low light

LED

Three colour

Alarm notifications

Visual, audio and vibration

Device size

173.1mm x 79mm x 41.1mm

Device weight

660 g (1.47 lb)

File storage

ANSI N42.42

Confirmation mode

30 sec to 5 minutes

False alarm rate

Better than ANSI N42.34 (2015)

Isotope ID

ANSI N42.34 (2015)

Hardware compliance

ANSI N42.34 (2015)

Rugged military standard compliance

MIL-STD-810Gm w/Charge 1

Calibration stabilisation

Sourceless natural atmospheric

 

* Area efficiency = Aε662 keV /R662 keV1.5 

 

For further information, please contact:

 

Kromek Group plc

 

Arnab Basu, CEO

Paul Farquhar, CFO

 

+44 (0)1740 626 060

Luther Pendragon (PR)

 

Harry Chathli

Claire Norbury

Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and

https://twitter.com/kromekgroup.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAKKBBNKBDBOBK
Date   Source Headline
25th Apr 20247:00 amRNSKromek receives new Nuclear Security contract
3rd Apr 20243:13 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSKromek receives $2.1m security screening order
6th Mar 20243:21 pmRNSHolding(s) in Company
4th Mar 202412:16 pmRNSHolding(s) in Company
4th Mar 202411:51 amRNSResult of General Meeting
5th Feb 202410:17 amRNSConversion of £1.5m of Convertible Loan Notes
5th Feb 20247:00 amRNSKromek granted £1.3m under Horizon Europe scheme
30th Jan 20247:00 amRNSInterim Results
25th Jan 20247:00 amRNSKromek receives £1.4m CBRN order for EU stockpile
23rd Jan 20247:00 amRNSNotice of Results
18th Jan 20247:00 amRNSKromek receives $1.6m in advanced imaging orders
7th Nov 20237:00 amRNSCollaboration agreement with new CT partner
31st Oct 20237:00 amRNSKromek receives additional $1m in CBRN orders
26th Oct 20237:00 amRNSFirst US DHS Contract for Biosecurity for $5.9m
9th Oct 20234:59 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSHolding(s) in Company
28th Sep 202311:25 amRNSResult of AGM
28th Sep 20237:00 amRNSFinancing Update
14th Sep 20237:00 amRNSPartial Conversion of Convertible Loan Notes
12th Sep 20237:00 amRNSKromek detectors in new Spectrum Dynamics scanner
1st Sep 20235:00 pmRNSNotice of AGM and Publication of Annual Report
24th Jul 20237:01 amRNSFinal Results
24th Jul 20237:00 amRNSAppointment of Joint Broker
5th Jun 20237:00 amRNSNew $1.5m CBRN contract in Asia
31st May 20239:05 amRNSHolding(s) in Company
25th May 20232:48 pmRNSResult of Open Offer, General Meeting and TVR
10th May 20231:39 pmRNSNotice of Investor Webinar
5th May 20233:46 pmRNSPlacing, Subscription, Open Offer and Notice of GM
2nd May 20237:00 amRNSKromek receives medical imaging order of c.$1.4m
19th Apr 20237:00 amRNSKromek and Analogic Collaboration Agreement
18th Apr 20237:01 amRNSTrading Update
18th Apr 20237:00 amRNSSeven-Year Agreement with Tier 1 OEM
29th Mar 20237:00 amRNSKromek secures orders totalling over $1m
22nd Mar 20232:51 pmRNSHolding(s) in Company
31st Jan 20237:00 amRNSInterim Results
31st Jan 20237:00 amRNSKromek awarded c. £2.5m by Innovate UK
9th Jan 20237:00 amRNSKromek Secures $0.8m Order for D3S ID
19th Dec 20227:00 amRNSFurther agreement with Smiths Detection
15th Dec 20229:32 amEQSKromek Group 'delighted' with new contracts
12th Dec 20227:00 amRNSKromek wins £1.5m in nuclear security contracts
16th Nov 20227:00 amRNSAward of £5m bio-threat contract by UK Government
10th Nov 20227:00 amRNSKromek awarded US nuclear security contract
17th Oct 202211:42 amRNSKromek detectors used in digital SPECT/CT scanner
28th Sep 202212:27 pmRNSResult of AGM
2nd Sep 20225:26 pmRNSNotice of AGM and Publication of Annual Report
23rd Aug 202211:10 amRNSFundraising of £1.14 million
5th Aug 20227:00 amRNSFundraising of £1.7m
3rd Aug 20222:05 pmRNSSecond Price Monitoring Extn
3rd Aug 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.